Health Canada Issues Important Safety Info to Healthcare Professionals Advising of Elmiron Pigmentary Maculopathy Risks
North America - December 17, 2020 - Health Canada, a government agency responsible for Canada's federal health policies, issued an "Important Safety Information" letter (RA-74549) warning healthcare providers about Elmiron (Pentosan Polysulfate Sodium) Pigmentary Maculopathy Risks. Health Canada announced two new updates concerning … [Read more...] about Health Canada Issues Important Safety Info to Healthcare Professionals Advising of Elmiron Pigmentary Maculopathy Risks
Press Release – Parker Waichman LLP Reports Plaintiffs Win Motion to Centralize All Pending National Elmiron® Retinal Damage Lawsuits to the District of New Jersey
PORT WASHINGTON, N.Y., December 16, 2020 /PRNewswire/ -- Parker Waichman LLP, a national law firm actively involved in the Elmiron® litigation, announced today that plaintiffs were successful in their motion, under 28 USC § 1407, to centralize all pending Elmiron injury lawsuits filed in federal courts across the country in the … [Read more...] about Press Release – Parker Waichman LLP Reports Plaintiffs Win Motion to Centralize All Pending National Elmiron® Retinal Damage Lawsuits to the District of New Jersey
Elmiron® Pigmentary Maculopathy Lawsuits
Parker Waichman LLP Files an Elmiron® Lawsuit On Behalf of the Firm's Client in California Who Suffers Vision Loss, Pigmentary Maculopathy, & Irreversible Retinal Damage Due to Elmiron®. PORT WASHINGTON, NY - July 8, 2020 - According to an online press release published on PRNewswire.com, Parker Waichman LLP, a national … [Read more...] about Elmiron® Pigmentary Maculopathy Lawsuits
